A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients
HIV Infections
About this trial
This is an interventional treatment trial for HIV Infections focused on measuring HIV-1, Drug Therapy, Combination, Zidovudine, Drug Resistance, Microbial, HIV Protease Inhibitors, Lamivudine, Indinavir, Genotype, Reverse Transcriptase Inhibitors, efavirenz
Eligibility Criteria
Exclusion Criteria Concurrent Medication: Excluded: Terfenadine, astemizole, cisapride, triazolam, or midazolam (competition for the enzyme cytochrome P-450 3A4 [CYP3A4] by indinavir could result in inhibition of metabolic breakdown of these drugs and create the potential for serious and/or life threatening events [i.e., cardiac arrhythmia, prolonged sedation]). Rifampin or rifabutin (prohibited because of potential drug interaction with indinavir). Ketoconazole, itraconazole, and clarithromycin. Concomitant systemic therapy for acute opportunistic infection or malignancy. Excluded: Life expectancy less than 12 months. Prior Medication: Excluded: Prior treatment with efavirenz, 3TC, an NNRTI, or an HIV protease inhibitor. Prior antiretroviral agent within 14 days of initiating study treatment. Prior treatment (within 30 days of initiating study treatment) with any other experimental drug for any indication. Patients must: Have a diagnosis of HIV infection. Have CD4 counts greater than or equal to 50 cell/mm3. Have a life expectancy greater than or equal to 12 months. Be post-pubescent.
Sites / Locations
- Phoenix Body Positive
- Arizona Clinical Research Ctr Inc
- Richard Stryker
- Paul Cimoch
- AIDS Healthcare Foundation
- Kraus Med Group
- Oasis Clinic / Martin Luther Jr Gen Hosp / King-Drew Med Ctr
- Blick Med Associates
- Novum Inc
- Bach and Godofsky
- Community Research Initiative of South Florida
- Boulevard Comprehensive Care Ctr
- Larry Marc Bush / c/o Sally Yantis
- Univ of Miami School of Medicine
- Ctr for Quality Care
- Daniel Seekins
- Infectious Disease Research Institute
- Treasure Coast Infectious Disease Consultants
- Georgia Research Associates
- Med College of Georgia
- Infectious Diseases
- Univ of Kentucky Med Ctr
- Kansas City AIDS Research Consortium
- Univ of Nebraska Med Ctr / HIV Clinic
- Univ Med Ctr / HIV Wellness Ctr
- Community Research Initiative on AIDS
- Clinical Directors Network / HIV/AIDS Program Manager
- Wake Forest Univ School of Medicine
- Remington-Davis Inc
- Philadelphia FIGHT
- The Miriam Hosp
- Research Services 2000 Inc
- Division of Infectious Disease / Dept of Internal Medicine
- Research Services 2000 Inc
- Montrose Clinic
- UT-Health Science Ctr
- Diagnostic Clinic of San Antonio
- Oyster Point Med Specialists
- Novum Inc / Pharmaceutical Research Services
- Infectious Diseases Associates
- Javier O Morales Ramirez